Thursday, August 28, 2008
Inder Singh leads Clinton Foundation malaria drug acquisition initiative
Inder Singh, 31, director of the Clinton Foundation's Drug Access Program, part of CHAI or the Clinton Foundation HIV /AIDS Initiative, recently negotiated a landmark deal with four Indian and two Chinese companies to produce affordable malaria drugs for millions of sufferers in 69 countries.
"We completed agreements with suppliers at all levels of the production chain. These agreements are structured to reduce the volatility of the key raw ingredient [and cost driver] of these drugs, a plant derived material called artemisinin," Singh told News IndiaTimes. Prices for artemisinin have fluctuated wildly in recent years from a low of $150 per kilogram to a high of $1100 per kilogram, in other words more than 700 percent.
"Indian companies have become a god send for the production of high quality but low priced antiretrovirals for HIV/AIDS and they are now doing this for malaria, Singh noted. "The companies we are working with are able to produce medicines as high in quality as any of the major multinational pharmaceutical companies but in many instances at even lower costs," Singh said.
To read the full article, click here..
To read the epaper, visit: http://www.newsindia-times.com
"We completed agreements with suppliers at all levels of the production chain. These agreements are structured to reduce the volatility of the key raw ingredient [and cost driver] of these drugs, a plant derived material called artemisinin," Singh told News IndiaTimes. Prices for artemisinin have fluctuated wildly in recent years from a low of $150 per kilogram to a high of $1100 per kilogram, in other words more than 700 percent.
"Indian companies have become a god send for the production of high quality but low priced antiretrovirals for HIV/AIDS and they are now doing this for malaria, Singh noted. "The companies we are working with are able to produce medicines as high in quality as any of the major multinational pharmaceutical companies but in many instances at even lower costs," Singh said.
To read the full article, click here..
To read the epaper, visit: http://www.newsindia-times.com
Labels: antiretrovirals, CHAI, Clinton Foundation's Drug Access Program, HIV /AIDS, Inder Singh, malaria drugs, medicines, pharmaceutical companies, suppliers
Subscribe to Posts [Atom]
